Related Experiment Video
Updated: Feb 25, 2026
Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
IFITM1 is required for epithelial mesenchymal transition in airway remodeling of allergic asthma
Manni Zhu1,2, Xiaoqin Weng2,3, Chuanli Zhang2
1Department of Respiratory and Critical Care Medicine, Nantong First People's Hospital, Nantong, China.
Background:
Interferon-induced transmembrane protein 1 (IFITM1) restricts virus infection. IFITM proteins are involved in Th2 cell differentiation in allergic asthma. The epithelial‒mesenchymal transition (EMT) regulates allergic airway remodeling. We sought to explore the functional contributions and underlying mechanisms of IFITM1 in the EMT associated with allergic asthma.
Methods:
The expression of IFITM1 was measured in pulmonary tissues from asthma patients and in a house dust mite (HDM)-induced murine asthma model. The mechanisms by which IFITM1 affects the EMT of airway remodeling were investigated in vitro and in vivo via the use of an IFNAR neutralizing antibody or Ifitm1 knockdown.
Results:
We demonstrated that airway IFITM1 was increased in patients with asthma. As expected, HDM exposure increased airway IFITM1 in an asthmatic murine model. The increase in IFITM1 was mediated through IFN-β stimulation and subsequent STAT1 signaling activation. Blocking IFNAR or knocking down Ifitm1 mitigated HDM-induced EMT and airway remodeling. Mechanistically, HDM exposure increased IFITM1 and TNC levels in airway epithelial cells, which promoted Th17 cell differentiation and IL-17A production.
Conclusion:
IFIMT1, which is upregulated in airway epithelial cells via the IFN-β and STAT1 signaling pathways, contributes to EMT during allergic airway remodeling and may serve as a potential treatment target for allergic asthma.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:13Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:29Asthma-I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...